New (Trimethoxyphenylamino)Pyrimidinyl Formulations

Patent No. EP2736487 (titled "New (Trimethoxyphenylamino)Pyrimidinyl Formulations") was filed by Rigel Pharmaceuticals on Jul 26, 2012. The application was issued on Aug 28, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICAL INDUSTRIES LTDAug 7, 2019TER MEER STEINMEISTER & PARTNER GBR

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2736487

RIGEL PHARMACEUTICALS
Application Number
EP12759802A
Filing Date
Jul 26, 2012
Status
Patent Maintained As Amended
Jul 26, 2024
Publication Date
Aug 28, 2024